The results revealed that differences in FANCI expression do not explain the differential responses on FANCI depletion in PC-3 and LNCaP cells, as there are no statistically significant differences in FANCI expression between LNCaP, PC-3, 22Rv1, VCaP, and DU-145 prostate cancer cells at mRNA and protein levels (Supplementary Figure S1). Here, FANCI is linked to prostate cancer.